299 related articles for article (PubMed ID: 17976163)
1. Atorvastatin attenuates mitochondrial toxin-induced striatal degeneration, with decreasing iNOS/c-Jun levels and activating ERK/Akt pathways.
Lee ST; Chu K; Park JE; Hong NH; Im WS; Kang L; Han Z; Jung KH; Kim MW; Kim M
J Neurochem; 2008 Mar; 104(5):1190-200. PubMed ID: 17976163
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte-colony stimulating factor attenuates striatal degeneration with activating survival pathways in 3-nitropropionic acid model of Huntington's disease.
Lee ST; Park JE; Kim DH; Kim S; Im WS; Kang L; Jung SH; Kim MW; Chu K; Kim M
Brain Res; 2008 Feb; 1194():130-7. PubMed ID: 18166168
[TBL] [Abstract][Full Text] [Related]
3. Galantamine reduces striatal degeneration in 3-nitropropionic acid model of Huntington's disease.
Park JE; Lee ST; Im WS; Chu K; Kim M
Neurosci Lett; 2008 Dec; 448(1):143-7. PubMed ID: 18938211
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of acute inflammatory response by atorvastatin after spinal cord injury in rats.
Pannu R; Barbosa E; Singh AK; Singh I
J Neurosci Res; 2005 Feb; 79(3):340-50. PubMed ID: 15605375
[TBL] [Abstract][Full Text] [Related]
5. NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties.
Momi S; Impagnatiello F; Guzzetta M; Caracchini R; Guglielmini G; Olivieri R; Monopoli A; Gresele P
Eur J Pharmacol; 2007 Sep; 570(1-3):115-24. PubMed ID: 17632098
[TBL] [Abstract][Full Text] [Related]
6. Participation of par-4 in the degeneration of striatal neurons induced by metabolic compromise with 3-nitropropionic acid.
Duan W; Guo Z; Mattson MP
Exp Neurol; 2000 Sep; 165(1):1-11. PubMed ID: 10964480
[TBL] [Abstract][Full Text] [Related]
7. c-Jun N-terminal kinase and p38 mitogen-activated protein kinase mediate double-strand RNA-induced inducible nitric oxide synthase expression in microglial cells.
Kong PJ; Lee HJ; Lee SH; Kim SY; Lee SN; Chun WJ; Kim SS
Neurosci Lett; 2008 Mar; 433(3):215-8. PubMed ID: 18258363
[TBL] [Abstract][Full Text] [Related]
8. 3-nitropropionic acid-induced mitochondrial permeability transition: comparative study of mitochondria from different tissues and brain regions.
Mirandola SR; Melo DR; Saito A; Castilho RF
J Neurosci Res; 2010 Feb; 88(3):630-9. PubMed ID: 19795369
[TBL] [Abstract][Full Text] [Related]
9. Systemic administration of 3-nitropropionic acid points out a different role for active caspase-3 in neurons and astrocytes.
Duran-Vilaregut J; Del Valle J; Manich G; Junyent F; Camins A; Pallàs M; Pelegrí C; Vilaplana J
Neurochem Int; 2010 Feb; 56(3):443-50. PubMed ID: 19969037
[TBL] [Abstract][Full Text] [Related]
10. Involvement of nitric oxide in 3-nitropropionic acid-induced striatal toxicity in rats.
Deshpande SB; Hida H; Takei-Io N; Masuda T; Baba H; Nishino H
Brain Res; 2006 Sep; 1108(1):205-15. PubMed ID: 16857175
[TBL] [Abstract][Full Text] [Related]
11. Intrathecally injected granulocyte colony-stimulating factor produced neuroprotective effects in spinal cord ischemia via the mitogen-activated protein kinase and Akt pathways.
Chen WF; Jean YH; Sung CS; Wu GJ; Huang SY; Ho JT; Su TM; Wen ZH
Neuroscience; 2008 Apr; 153(1):31-43. PubMed ID: 18358629
[TBL] [Abstract][Full Text] [Related]
12. Posttranslational activation of endothelial nitric oxide synthase attenuates carbon tetrachloride-induced hepatotoxicity in newborn rats.
Liu H; Subramony C; Nowicki M
Pediatr Res; 2008 Jun; 63(6):613-9. PubMed ID: 18317400
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones.
Bösel J; Gandor F; Harms C; Synowitz M; Harms U; Djoufack PC; Megow D; Dirnagl U; Hörtnagl H; Fink KB; Endres M
J Neurochem; 2005 Mar; 92(6):1386-98. PubMed ID: 15748157
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effect of L-carnitine in the 3-nitropropionic acid (3-NPA)-evoked neurotoxicity in rats.
Binienda Z; Virmani A; Przybyla-Zawislak B; Schmued L
Neurosci Lett; 2004 Sep; 367(2):264-7. PubMed ID: 15331167
[TBL] [Abstract][Full Text] [Related]
15. Sildenafil protects against 3-nitropropionic acid neurotoxicity through the modulation of calpain, CREB, and BDNF.
Puerta E; Hervias I; Barros-Miñones L; Jordan J; Ricobaraza A; Cuadrado-Tejedor M; García-Osta A; Aguirre N
Neurobiol Dis; 2010 May; 38(2):237-45. PubMed ID: 20109548
[TBL] [Abstract][Full Text] [Related]
16. Multiple molecular pathways are involved in the neuroprotection of GDNF against proteasome inhibitor induced dopamine neuron degeneration in vivo.
Du Y; Li X; Yang D; Zhang X; Chen S; Huang K; Le W
Exp Biol Med (Maywood); 2008 Jul; 233(7):881-90. PubMed ID: 18445767
[TBL] [Abstract][Full Text] [Related]
17. Whole body hyperthermia reduces oxidative stress in the striatum of rats in an animal model of mitochondrial toxicity with 3-nitropropionic acid.
Medina-Navarro R; Guerrero-Linares I
Int J Hyperthermia; 2009 Jun; 25(4):280-8. PubMed ID: 19440936
[TBL] [Abstract][Full Text] [Related]
18. IGF-1 exacerbates the neurotoxicity of the mitochondrial inhibitor 3NP in rats.
Escartin C; Boyer F; Bemelmans AP; Hantraye P; Brouillet E
Neurosci Lett; 2007 Oct; 425(3):167-72. PubMed ID: 17868993
[TBL] [Abstract][Full Text] [Related]
19. Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington's disease in rats.
Pandey M; Borah A; Varghese M; Barman PK; Mohanakumar KP; Usha R
Neurochem Int; 2009 Nov; 55(6):431-7. PubMed ID: 19410615
[TBL] [Abstract][Full Text] [Related]
20. Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid.
Dautry C; Vaufrey F; Brouillet E; Bizat N; Henry PG; Condé F; Bloch G; Hantraye P
J Cereb Blood Flow Metab; 2000 May; 20(5):789-99. PubMed ID: 10826529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
